J.Jpn. Surg. Soc.. 80(4): 299-306, 1979
Original article
STUDIES ON TUMOR-SPECIFIC CELL-MEDIATED IMMUNITY IN CANCER PATIENTS USING A MIXED LYMPHOCYTE-TUMOR CELL CULTURE REACTION
PART II. CORRELATION BETWEEN MLTR AND NON-SPECIFIC IMMUNOLOGICAL REACTIVITY AND PROGNOSIS
|
Department of Surgery, Research Institute for Nuclear Medicine and Biology, Hiroshima University, Hiroshima (Director : Prof. T. Hattori) Hiroshi IKEDA |
1) Positive blasstogenic responses in MLTR were observed in 15 of 56 cancer patients.
2) MLTR was well related to DNCB skin test (P＜0.001), but not to PPD or PHA skin tests.
3) Peripheral lymphocyte count was not significantly related to MLTR. However, lymphocyte count was more than 2,000/mm3 in 10 of 12 positive cases for MLTR.
4) Serum immunoglobulin level was not related to MLTR .
5) In gastric cancer patients, positive blastogenic responses were observed in 1 of 8, 4 of 11 and 3 of 20 patients, in stage I+ II, stage III and stage IV, respectively.
6) In non-curative cases, a significant correlation was indicated between MLTR and prognosis (r=0.782, P＜0.001).
Finally, it was suggested that the intensity of tumor specific immune response was related to general immunocompetence and prognosis.
To read the PDF file you will need Adobe Reader installed on your computer.